Preventing the unfolded protein response via aberrant activation of 4E-binding protein 1 by versipelostatin
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-02-10
著者
-
SHIN-YA Kazuo
Biomedicinal Information Research Center (BIRC), National Institute of Advanced Industrial Science a
-
Tomida Akihiro
癌研究会癌化学療法センター
-
Shin-ya Kazuo
Biomedical Information Research Center National Institute Of Advanced Industrial Sciences And Techno
-
Sakurai Junko
The Cancer Chemotherapy Center Japanese Foundation For Cancer Research (jfcr)
-
Watanabe Toshiki
Laboratory Of Tumor Cell Biology Department Of Medical Genome Sciences Graduate School Of Frontier S
-
TSUKUMO Yoshinori
The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research (JFCR)
-
MATSUO Junichi
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
TSUKUMO Yoshinori
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
SAKURAI Junko
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
TSUKAHARA Satomi
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
PARK Hae-Ryong
Department of Food Science and Biotechnology, Kyungnam University 449 Wolyoung-dong
-
TSURUO Takashi
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
TOMIDA Akihiro
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
Tsuruo Takashi
Division Of Molecular Oncology Aichi Cancer Center Research Institute
-
Tsuruo Takashi
The Cancer Chemotherapy Center Japanese Foundation For Cancer Research (jfcr)
-
Tsuruo Takashi
Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Tsuruo Takashi
Cancer Chemotherapy Center
-
Tsuruo Takeshi
Institute Of Molecular And Cellular Biosciences University Of Tokyo
-
Watanabe Toshiki
Laboratory Of Tumor Cell Biology Department Of Medical Genome Science Graduate School Of Frontier Sc
-
Park Hae-ryong
Department Of Food Science And Biotechnology Kyungnam University 449 Wolyoung-dong
-
Tsuruo T
The Cancer Chemotherapy Center Japanese Foundation For Cancer Research (jfcr)
-
Matsuo Junichi
Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Tsuruo T
Japanese Foundation For Cancer Research Tokyo Jpn
-
Takeshita Akihiro
Department Of Medicine Iii Hamamatsu University School Of Medicine
-
Tsukahara Satomi
Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Park Hae-ryong
Department Of Food Science And Biotechnology Kyungnam University
-
Tsukumo Yoshinori
The Cancer Chemotherapy Center Japanese Foundation For Cancer Research (jfcr)
-
Tomida Akihiro
Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Toki Asami
Graduate School Of Science And Technology Niigata University
-
Taniguchi Tetsuo
The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research (JFCR)
関連論文
- JBIR-26, a Novel Natural Compound from Streptomyces sp. AK-AH76, Regulates Mammalian Circadian Clock
- Diversity, Salt Requirement, and Antibiotic Production of Actinobacteria Isolated from Marine Sponges
- Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome-wide cDNA Microarray Analysis
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Case-control study of leukemia and diagnostic radiation exposure
- Good Prognosis of Patients With Acute Promyelocytic Leukemia Who Achieved Second Complete Remission (CR) With a New Retinoid, Am80, After Relapse From CR Induced by All-trans-Retionic Acid
- Multicenter Prospective Study of Interferon-α and Conventional Chemotherapy Versus Bone Marrow Transplantation for Newly Diagnosed Patients With Chronic Myelogenous Leukemia
- Two Cases of Acute Promyelocytic Leukemia Complicated by Torsade de Pointes during Arsenic Trioxide Therapy
- Two Patients with All-trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Treated Successfully with Gemtuzumab Ozogamicin as a Single Agent
- Delayed Recovery of Normal Hematopoiesis in Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia: A Comparison to All-trans Retinoic Acid Treatment
- Spicamycin and KRN5500 Induce Apoptosis in Myeloid and Lymphoid Cell Lines with Down-regulation of Bcl-2 Expression and Modulation of Promyelocytic Leukemia Protein
- Relapse in the External Auditory Canal of Acute Promyelocytic Leukemia after Treatment with All-Trans Retinoic Acid
- Allergic Reaction Involving Liver Dysfunction and Disseminated Intravascular Coagulation Caused by a Health Food, Proporis
- A Novel Versipelostatin Analogue, Versipelostatin F Isolated from Streptomyces versipellis 4083-SVS6
- Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
- JBIR-15, a New Aspochracin Derivative, Isolated from a Sponge-Derived Fungus, Aspergillus sclerotiorum Huber Sp080903f04
- JBIR-37 and -38, Novel Glycosyl Benzenediols, Isolated from the Sponge-Derived Fungus, Acremonium sp. SpF080624G1f01
- Catechin, green tea component, causes caspase-independent necrosis-like cell death in chronic myelogenous leukemia
- TUSC4/NPRL2, a novel PDK1-interacting protein, inhibits PDK1 tyrosine phosphorylation and its downstream signaling
- Involvement of mitochondrial aggregation in arsenic trioxide (As_2O_3)-induced apoptosis in human glioblastoma cells
- MOLECULAR TARGETING THERAPY OF CANCER : DRUG RESISTANCE, APOPTOSIS AND SURVIVAL SIGNAL
- Molecular targeting therapy of cancer : drug resistance, apoptosis and survival signal
- Mitochondria regulate the unfolded protein response leading to cancer cell survival under glucose deprivation conditions
- Preventing the unfolded protein response via aberrant activation of 4E-binding protein 1 by versipelostatin
- Serum level of soluble CD30 correlates with the aggressiveness of adult T-cell leukemia/lymphoma
- JBIR-66, a New Metabolite Isolated from Tunicate-Derived Saccharopolyspora sp. SS081219JE-28
- Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages
- Arrhythmogenic Effects of Arsenic Trioxide in Patients With Acute Promyelocytic Leukemia and an Electrophysiological Study in Isolated Guinea Pig Papillary Muscles
- Platelet aggregation in the formation of tumor metastasis
- Isolation of a cDNA Encoding a Chitinase Family Protein from Cuticular Tissues of the Kuruma Prawn Penaeus japonicus
- A New Quinoline Derivative MS-209 Reverses Multidrug Resistance and Inhibits Multiorgan Metastases by P-glycoprotein-expressing Human Small Cell Lung Cancer Cells
- POTENTIATION OF CHEMOTHERAPEUTIC EFFECT OF VINCRISTINE IN VINCRISTINE RESISTANT TUMOR BEARING MICE BY CALMODULIN INHIBITOR CLOMIPRAMINE
- ANTITUMOR EFFICACIES OF ACLACINOMYCIN A BY ORAL ADMINISTRATION
- High-level Expression of P-glycoprotein and 85 kD Protein as Assessed by Flow Cytometry and Immunocytochemistry in Leukemias and Malignant Lymphomas
- Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1 and LPA2
- Combination Therapy with Antibody and Interleukin-2 Gene Transfer against Multidrug-resistant Cancer Cells
- Transduction of the Macrophage Colony-stimulating Factor Gene into Human Multidrug Resistant Cancer Cells : Enhanced Therapeutic Efficacy of Monoclonal Anti-P-glycoprotein Antibody in Nude Mice
- Expression of Carbohydrate-Binding Protein p33/41 in Human Tumor Cell Lines
- Molecular Cloning of a Molt-Inhibiting Hormone cDNA from the Kuruma Prawn Penaeus japonicus
- Immunological Quantitation of DT-Diaphorase in Carcinoma Cell Lines and Clinical Colon Cancers : Advanced Tumors Express Greater Levels of DT-Diaphorase
- Acute Induction of Adriamycin-resistance in Human Colon Carcinoma HT-29 Cells Exposed to a Sublethal Dose of Adriamycin
- Elevation of the activities of β-N-acetylhexosaminidase isozymes by 20-hydroxyecdysone administration in the kuruma prawn
- The polar neutral and basic taxoids isolated from needles and twigs of Taxus cuspidata and their biological activity
- A New Taxoid from a Callus Culture of Taxus cuspidata as an MDR Reversal Agent
- Inhibition of Tumor Cell Invasion and Matrix Degradation by Aminopeptidase Inhibitors
- A NOVEL ANTITUMOR CYCLIC HEXAPEPTIDE (RA-700) OBTAINED FROM RUBIAE RADIX
- Inhibitory Effect of ATF3 Antisense Oligonucleotide on Ectopic Growth of HT29 Human Colon Cancer Cells
- Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export
- Hodgkin's Lymphoma and CD30 Signal Transduction
- A novel domain in the CD30 cytoplasmic tail mediates NFkB activation
- Identification and Characterization of a Deletion Mutant of DNA Topoisomerase I mRNA in a Camptothecin-resistant Subline of Human Colon Carcinoma
- Dereplication of Streptomyces Strains by Automated Southern Hybridization with a Polyketide Synthase Gene Probe
- Inhibition by Differentiation-inducing Agents of Wild-type p53-dependent Apoptosis in HL-60 Cells
- Selective Cytotoxicity of Ponciri Fructus against Glucose-Deprived PANC-1 Human Pancreatic Cancer Cells via Blocking Activation of GRP78
- JBIR-66, a New Metabolite Isolated from Tunicate-Derived Saccharopolyspora sp. SS081219JE-28
- JBIR-37 and -38, Novel Glycosyl Benzenediols, Isolated from the Sponge-Derived Fungus, Acremonium sp. SpF080624G1f01
- JBIR-15, a New Aspochracin Derivative, Isolated from a Sponge-Derived Fungus, Aspergillus sclerotiorum Huber Sp080903f04
- Selective Cytotoxicity of Ponciri Fructus against Glucose-Deprived PANC-1 Human Pancreatic Cancer Cells via Blocking Activation of GRP78
- Protective Effects of Paeonia lactiflora Pall on Hydrogen Peroxide-Induced Apoptosis in PC12 Cells
- The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma
- Polar cardenolide monoglycosides from stems and twigs of Nerium oleander and their biological activities
- Actinobacteria Associated with the Marine Sponges Cinachyra sp., Petrosia sp., and Ulosa sp. and Their Culturability
- New species of actinomycetes do not always produce new compounds with high frequency
- Isolation of a novel macrocyclic dilactone-JBIR-101-from Promicromonospora sp. RL26
- A new cyclizidine analog-JBIR-102-from Saccharopolyspora sp. RL78 isolated from mangrove soil
- JBIR-52, a new antimycin-like compound, from Streptomyces sp. ML55
- Novel 24-membered macrolides, JBIR-19 and -20 isolated from Metarhizium sp. fE61
- Screening and evaluation of new inhibitors of hepatic glucose production
- JBIR-124 : a novel antioxidative agent from a marine sponge-derived fungus Penicillium citrinum Spl080624G1fO1
- JBIR-17, a novel trichostatin analog from Streptomyces sp. 26634
- New angucycline C-glycosides from Streptomyces sp. RI33
- JBIR-12, a novel antioxidative agent from Penicillium sp. NBRC 103941
- Two novel benzastatin derivatives, JBIR-67 and JBIR-73, isolated from Streptomyces sp. RI18
- JBIR-54, a new 4-pyridinone derivative isolated from Penicillium daleae Zaleski fE50
- New sesquiterpenes, JBIR-27 and -28, isolated from a tunicate-derived fungus, Penicillium sp. SS080624SCf1
- JBIR-25, a novel antioxidative agent from Hyphomycetes sp. CR28109
- Novel siderophore, JBIR-16, isolated from Nocardia tenerifensis NBRC 101015
- JBIR-44, a new bromotyrosine compound from a marine sponge Psammaplysilla purpurea
- Isolation of 2 new naphthablin analogs, JBIR-79 and JBIR-80, from Streptomyces sp. RI24
- New tensidols, JBIR-86 and JBIR-87, isolated from Aspergillus sp. fJ80
- Isolation and structure elucidation of tumescenamides A and B, two peptides produced by Streptomyces tumescens YM23-260
- A new angucycline and a new butenolide isolated from lichen-derived Streptomyces spp.
- JBIR-83 and JBIR-84, new promothiocin derivatives, isolated from Streptomyces sp. RI19
- JBIR-65, a new diterpene, isolated from a spongederived Actinomadura sp. SpB081030SC-15
- Isolation of 2 new metabolites, JBIR-74 and JBIR-75, from the sponge-derived Aspergillus sp. fS14
- A new 16-membered tetraene macrolide JBIR-100 from a newly identified Streptomyces species
- New xanthoquinodin-like compounds, JBIR-97, -98 and -99, obtained from marine sponge-derived fungus Tritirachium sp. SpB081112MEf2
- Isolation of two new terpeptin analogs-JBIR-81 and JBIR-82-from a seaweed-derived fungus, Aspergillus sp. SpD081030G1f1
- Flaviogeranin, a new neuroprotective compound from Streptomyces sp.
- JBIR-59, a new sorbicillinoid, from a marine-derived fungus Penicillium citrinum SpI080624G1f01
- JBIR-14, a highly oxygenated ergostane, from Isaria sp. NBRC 104353
- JBIR-31, a new teleocidin analog, produced by salt-requiring Streptomyces sp. NBRC 105896 isolated from a marine sponge
- Three new depsipeptides, JBIR-113, JBIR-114 and JBIR-115, isolated from a marine sponge-derived Penicillium sp. fS36
- JBIR-120 : a new growth inhibitor of hormone-refractory prostate cancer cells
- JBIR-69, a new metabolite from Streptomyces sp. OG05
- Construction of a natural product library containing secondary metabolites produced by actinomycetes
- JBIR-58, a new salicylamide derivative, isolated from a marine sponge-derived Streptomyces sp. SpD081030ME-02
- JBIR-137 and JBIR-138, new secondary metabolites from Aspergillus sp. fA75
- A new furaquinocin derivative, JBIR-136, from Streptomyces sp. 4963H2